MorphoSys AG: Due to Sale and Transfer of Tafasitamab, 2024 Fincl Guidance Published on Jan 30 Cannot Be Maintained and Therefore Was Revoked >MOR.FF
MorphoSys AG: Due to Sale and Transfer of Tafasitamab, 2024 Fincl Guidance Published on Jan 30 Cannot Be Maintained and Therefore Was Revoked >MOR.FF
MorphoSys AG：由于Tafasitamab的出售和转让，1月30日发布的2024年Fincl指南无法维持，因此被撤销 >MOR.FF
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册